PRIORITIZE - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

PRIORITIZE

Description:

VACCINES and VACCINE PROTOCOLS Canine and Feline Vaccination Failures Vaccines do not produce immunity in ... Bordetella, Canine Influenza, Lyme disease, Canine ... – PowerPoint PPT presentation

Number of Views:157
Avg rating:3.0/5.0
Slides: 23
Provided by: BUNN4
Category:

less

Transcript and Presenter's Notes

Title: PRIORITIZE


1
PRIORITIZE
  • We must not sacrifice our future for a momentary
    pleasure.

2
VACCINES and VACCINE PROTOCOLS
  • Canine and Feline

3
Vaccination Failures
  • Vaccines do not produce immunity in 100 of
    population
  • Should decrease severity
  • Protection of 70 of population sufficient if
    communicability is low
  • In general practice, 1 vaccine break constitutes
    a failure

4
MODIFIED LIVE vs. KILLED
  • MLV
  • Strong, long-lasting immune response that is
    achieved with fewer doses
  • Adjuvants are not as necessary
  • Quicker immune respones
  • Less chance of allergic reactions
  • After it is mixed only effective 1 hour
  • KILLED (inactivated)
  • More stable in storage
  • Unlikely to contain contaminating pathogens
  • Unlikely to cause disease due to residual
    disease-causing characteristics
  • Produce little to no cellular and mucosal immunity

NO VACCINE IS 100 EFFECTIVE!
5
ADJUVANTS
  • Chemicals, microbial components, or mammalian
    proteins
  • Enhances the immune response to vaccine antigens
  • Aluminum gels/ salts

6
CORE VACCINE
  • Severity of disease
  • Transmissibility
  • Zoonotic potential

7
CORE VACCINESWHAT ARE THEY?
  • Those vaccines that every puppy should receive
    identified by vaccine experts such as the AAHA
    Canine Task Force
  • CORE VACCINES FOR CANINES INCLUDE
  • Canine parvovirus type 2 (CPV-2)
  • Canine Distemper virus (CDV)
  • rCDV Recombinat

8
CORE VACCINES
  • Canine Adenovirus type 2 (CAV-2)
  • CAV-2 protects both 1 2
  • Infectious Canine Heaptitis
  • No CAV-1 because of anterior uveitis
  • Hepatitis blue ice
  • Rabies virus (RV)
  • Killed vaccine
  • State/provincial/local laws

9
VACCINES GENERAL GUIDELINES
  • Begin 6-9 weeks of age
  • Do not give vaccines earlier than 5-6 weeks
  • remember maternal antibody interference
  • Frequency q 2-4 weeks
  • May vary according to risk, vaccine
  • End at least one dose should be given at age
    14-16 weeks of age or older
  • Revaccination at 1 year of age or 1 year after
    the last puppy vaccination

10
VACCINES-SPECIAL CONSIDERATIONS, RABIES
VACCINATION
  • Rabies vaccine is initially given at 12 wks of
    age
  • Does not need to be boostered in 2-4 weeks, but
    rather within 12 months. Each subsequent rabies
    vaccine should be given q 3yrs.
  • Rabies vaccine is the only canine vaccine
    requiring a minimum duration of immunity study
    and labeled as 1 yr or 3 yr. by the USDA.

11
VACCINES-DURATION OF IMMUNITY
  • The minimum duration of immunity for the core
    vaccines (except rabies) is at least 5-7 yrs.
    (after initial puppy set of vxns)
  • based on challenge and/or antibody titers
  • you can even have this done in your own pets to
    determine his/her immunity level against a
    particular disease.
  • Today, a 3 yr revaccination program has been
    recommended in the AAHA Canine Vaccination
    Guidelines for dogs and the American Association
    of Feline Practitioners Guidelines for cats

12
SO WHY DO WE VACCINATE EVERY YEAR?
  • Following the vaccine label
  • Veterinarians resistant to change
  • Fear that not revaccinating will cause the animal
    to become susceptible soon after one year.
  • Compliance with boarding kennel rules

13
VACCINES-NON-CORE
  • Optional or non-core vaccines should only be
    given to animals that need them and only as often
    as needed!
  • Potential problems duration of immunity is not
    known, the efficacy is limited or not known
  • EX Leptospirosis, Bordetella, Canine Influenza,
    Lyme disease, Canine coronavirus, Giardia (AAHA
    Guidelines do not recommend coronavirus or
    giardia vaccines unless they can be proven to be
    beneficial for a certain animal)

14
VACCINES-NON-CORE
  • New vaccines snakebites (Crotalus sp. Toxoid,
    western diamonback rattlesnake), periodontal
    disease (porphyromonas sp.), as well as a
    therapeutic vaccine for treatment of canine
    melanomas.
  • VACCINES MUST BE TAILORED
  • TO THE INDIVIDUAL ANIMAL
  • -Older/younger animal vs. adult
  • - bacterial vaccine vs. viral vaccine
  • Geographic area

15
VACCINES-GENERAL GUIDELINES IN FELINES
  • Begin 8-10 weeks of age
  • Frequency q 2-4 weeks
  • End last dose at 14-16 weeks of age

16
VACCINES-FELINE CONSIDERATIONS
17
CORE VACCINES-FELINE
  • Feline parvovirus (panleukopenia)
  • Feline calicivirus
  • Feline herpes virus (viral rhinotracheitis)
  • Rabies virus
  • Given at 12-16 weeks of age
  • FVRCP

18
VACCINES-NON-CORE
  • FeLV (feline leukemia)
  • FIV (feline immunodeficiency virus)
  • Chlamydia
  • Feline coronavirus (FIP)
  • Feline Giardia
  • Bordetella bronchiseptica
  • Feline systemic calicivirus

19
VACCINE QUESTIONS
  • May I use smaller vaccine dose in small breeds to
    reduce the risk of adverse reactions?
  • NO- the volume (1.0ml) as recommended by the
    manufacturer generally represents the minimum
    immunizing dose
  • This means that a Great Dane should receive the
    same amount of vaccine as a Chihuahua

20
VACCINE QUESTIONS
  • May I vaccinate pregnant pets?
  • It is best to avoid this. Risk to the fetuses is
    a concern. Assess risk vs. benefit

21
VACCINE QUESTIONS
  • May I vaccinate a patient while under anesthesia?
  • It is best not to do this. The patient may
    develop a hypersensitivity reaction that may be
    harder to recognize under anesthesia and may be
    more difficult to treat. Risk of vomiting and
    aspiration is higher.

22
VACCINE QUESTIONS
  • May I inject a modified live intranasal
    Bordetella vaccine?
  • NO- the vaccine can cause a severe local reaction
    and may even result in death (liver disease)
  • Intranasal vaccines are effective against
    respiratory disease, form immunoglobulin A which
    produces quick local immunity
Write a Comment
User Comments (0)
About PowerShow.com